Upregulation of brain hepcidin in prion diseases

References

• Requena JR. The protean prion protein. PLoS Biol. 2020;18(6):e3000754.
   PubMed Web of Science ®Google Scholar
• Sigurdson CJ, Bartz JC, Glatzel M. Cellular and molecular mechanisms of prion disease. Annu Rev Pathol. 2019;14(1):497–516.
   PubMed Web of Science ®Google Scholar
• Singh N. The role of iron in prion disease and other neurodegenerative diseases. PLoS Pathog. 2014;10(9):e1004335.
   PubMed Web of Science ®Google Scholar
• Terry C, Wadsworth JDF. Recent advances in understanding mammalian prion structure: a mini review. Front Mol Neurosci. 2019;12:169.
   PubMed Web of Science ®Google Scholar
• Bogdan AR, Miyazawa M, Hashimoto K, et al. Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem Sci. 2016 Mar;41(3):274–286.
   PubMed Web of Science ®Google Scholar
• D’Mello SR, Kindy MC. Overdosing on iron: elevated iron and degenerative brain disorders. Exp Biol Med (Maywood). 2020 Oct;245(16):1444–1473.
   PubMed Web of Science ®Google Scholar
• Gasperini L, Meneghetti E, Legname G, et al. In absence of the cellular prion protein, alterations in copper metabolism and copper-dependent oxidase activity affect iron distribution. Front Neurosci. 2016;10:437.
   PubMed Web of Science ®Google Scholar
• Hwang D, Lee IY, Yoo H, et al. A systems approach to prion disease. Mol Syst Biol. 2009;5(1):252.
   PubMedGoogle Scholar
• Kell D. Journal club. Nature. 2009;460(7256):669–669.
   PubMedGoogle Scholar
• Kim BH, Jun YC, Jin JK, et al. Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapie-infected mice. Neurosci Lett. 2007 Jul 18;422(3):158–163.
   PubMed Web of Science ®Google Scholar
• Kim N-H, Park S-J, Jin J-K, et al. Increased ferric iron content and iron-induced oxidative stress in the brains of scrapie-infected mice. Brain Res. 2000;884(1–2):98–103.
   PubMed Web of Science ®Google Scholar
• Kozlowski H, Luczkowski M, Remelli M, et al. Copper, zinc and iron in neurodegenerative diseases (Alzheimer’s, Parkinson’s and prion diseases). Coord Chem Rev. 2012;256(19–20):2129–2141.
   Web of Science ®Google Scholar
• Pushie MJ, Pickering IJ, Martin GR, et al. Prion protein expression level alters regional copper, iron and zinc content in the mouse brain. Metallomics. 2011 Feb;3(2):206–214.
   PubMed Web of Science ®Google Scholar
• Singh A, Isaac AO, Luo X, et al. Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog. 2009 Mar;5(3):e1000336.
   PubMed Web of Science ®Google Scholar
• Liang T, Qian ZM, Mu MD, et al. Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism. iScience. 2020 Jul 24;23(7):101284.
   PubMed Web of Science ®Google Scholar
• Qian ZM, Ke Y. Hepcidin and its therapeutic potential in neurodegenerative disorders. Med Res Rev. 2020 Mar;40(2):633–653.
   PubMed Web of Science ®Google Scholar
• Raha AA, Vaishnav RA, Friedland RP, et al. The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease. Acta Neuropathol Commun. 2013;1(1):1–19.
   Google Scholar
• Vela D. The dual role of hepcidin in brain iron load and inflammation. Front Neurosci. 2018;12:740.
   PubMed Web of Science ®Google Scholar
• You LH, Yan CZ, Zheng BJ, et al. Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis. Cell Death Dis. 2017 Mar 16;8(3):e2676.
   PubMedGoogle Scholar
• Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. science. 2004;306(5704):2090–2093.
   PubMed Web of Science ®Google Scholar
• Sangkhae V, Nemeth E. Regulation of the Iron Homeostatic Hormone Hepcidin. Adv Nutr. 2017 Jan;8(1):126–136.
   PubMed Web of Science ®Google Scholar
• Ganz T. Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer. 2006 May 1;46(5):554–557.
   PubMed Web of Science ®Google Scholar
• Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Semin Hematol. 2009 Oct;46(4):387–393.
   PubMed Web of Science ®Google Scholar
• Kanamori Y, Murakami M, Sugiyama M, et al. Interleukin-1beta (IL-1beta) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein delta (C/EBPdelta) expression in hepatocytes. J Biol Chem. 2017 Jun 16;292(24):10275–10287.
   PubMed Web of Science ®Google Scholar
• Llorens F, Lopez-Gonzalez I, Thune K, et al. Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease. Front Aging Neurosci. 2014;6:198.
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Zhu C. Microglia in prion diseases. J Clin Invest. 2017 Sep 1;127(9):3230–3239.
   PubMed Web of Science ®Google Scholar
• Carroll JA, Neuroinflammation CB. Microglia, and cell-association during prion disease. Viruses. 2019 Jan 15;11(1):65.
   Web of Science ®Google Scholar
• Crespo I, Roomp K, Jurkowski W, et al. Gene regulatory network analysis supports inflammation as a key neurodegeneration process in prion disease. BMC Syst Biol. 2012;6(1):1–12.
   PubMedGoogle Scholar
• Obst J, Simon E, Mancuso R, et al. The role of microglia in prion diseases: a paradigm of functional diversity. Front Aging Neurosci. 2017;9:207.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Katorcha E, Makarava N, et al. Inflammatory response of microglia to prions is controlled by sialylation of PrP(Sc). Sci Rep. 2018 Jul 27;8(1):11326.
   PubMedGoogle Scholar
• Aguzzi A, Nuvolone M, Zhu C. The immunobiology of prion diseases. Nat Rev Immunol. 2013 Dec;13(12):888–902.
   PubMed Web of Science ®Google Scholar
• Singh A, Qing L, Kong Q, et al. Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains. Neurobiol Dis. 2012 Mar;45(3):930–938.
   PubMed Web of Science ®Google Scholar
• Kulaksiz H, Gehrke S, Janetzko A, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 2004;53(5):735–743.
   PubMed Web of Science ®Google Scholar
• Walker A, Partridge J, Srai S, et al. Hepcidin: what every gastroenterologist should know. Gut. 2004;53(5):624–627.
   PubMed Web of Science ®Google Scholar
• Stefanova D, Raychev A, Deville J, et al. Hepcidin protects against lethal Escherichia coli sepsis in mice inoculated with isolates from septic patients. Infect Immun. 2018;86(7):7.
   Web of Science ®Google Scholar
• Ashok A, Kanwar JR, Krishnan UM, et al. SurR9C84A protects and recovers human cardiomyocytes from hypoxia induced apoptosis. Exp Cell Res. 2017 Jan 1;350(1):19–31.
   PubMed Web of Science ®Google Scholar
• Dikalov SI, Harrison DG. Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid Redox Signal. 2014;20(2):372–382.
   PubMed Web of Science ®Google Scholar
• Mishra RS, Basu S, Gu Y, et al. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci. 2004 Dec 15;24(50):11280–11290.
   PubMed Web of Science ®Google Scholar
• Basu S, Mohan ML, Luo X, et al. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis. Mol Biol Cell. 2007 Sep;18(9):3302–3312.
   PubMed Web of Science ®Google Scholar
• Asthana A, Baksi S, Ashok A, et al. Prion protein facilitates retinal iron uptake and is cleaved at the β-site: implications for retinal iron homeostasis in prion disorders. Sci Rep. 2017;7(1):1–14.
   PubMedGoogle Scholar
• Singh N, Haldar S, Tripathi AK, et al. Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal. 2014 Mar 10;20(8):1324–1363.
   PubMed Web of Science ®Google Scholar
• Carroll JA, Striebel JF, Race B, et al. Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction. J Virol. 2015 Feb;89(4):2388–2404.
   PubMed Web of Science ®Google Scholar
• Carroll JA, Striebel JF, Rangel A, et al. Prion strain differences in accumulation of PrPSc on neurons and glia are associated with similar expression profiles of neuroinflammatory genes: comparison of three prion strains. PLoS Pathog. 2016 Apr;12(4):e1005551.
   PubMed Web of Science ®Google Scholar
• Na Y-J, Jin J-K, Kim J-I, et al. JAK-STAT signaling pathway mediates astrogliosis in brains of scrapie-infected mice. J Neurochem. 2007 Oct;103(2):637–649.
   PubMed Web of Science ®Google Scholar
• Poli M, Asperti M, Ruzzenenti P, et al. Hepcidin antagonists for potential treatments of disorders with hepcidin excess. Front Pharmacol. 2014;5:86.
   PubMed Web of Science ®Google Scholar
• Abreu R, Quinn F, Giri PK. Role of the hepcidin-ferroportin axis in pathogen-mediated intracellular iron sequestration in human phagocytic cells. Blood Adv. 2018;2(10):1089–1100.
   PubMed Web of Science ®Google Scholar
• Urrutia P, Aguirre P, Esparza A, et al. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem. 2013 Aug;126(4):541–549.
   PubMed Web of Science ®Google Scholar
• Wang CY, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016 May;23(3):189–197.
   PubMed Web of Science ®Google Scholar
• Boserup MW, Lichota J, Haile D, et al. Heterogenous distribution of ferroportin-containing neurons in mouse brain. Biometals. 2011;24(2):357–375.
   PubMed Web of Science ®Google Scholar
• Sonntag KC, Tejada G, Subburaju S, et al. Limited predictability of postmortem human brain tissue quality by RNA integrity numbers. J Neurochem. 2016;138(1):53–59.
   PubMed Web of Science ®Google Scholar
• Gu Y, Jing Y, Kumar A, et al. Isolation of human neuronal cells resistant to toxicity by the prion protein peptide 106-126. J Alzheimers Dis. 2001;3(2):169–180.
   PubMed Web of Science ®Google Scholar
• Seibenhener ML, Wooten MW. Isolation and culture of hippocampal neurons from prenatal mice. J Vis Exp. 2012;65:65. DOI:https://doi.org/10.3791/3634
   Google Scholar
• Ashok A, Kang MH, Wise AS, et al. Prion protein modulates endothelial to mesenchyme-like transition in trabecular meshwork cells: implications for primary open angle glaucoma. Sci Rep. 2019;9(1):1–15.
   PubMedGoogle Scholar
• Ashok A, Singh N. Prion protein modulates glucose homeostasis by altering intracellular iron. Sci Rep. 2018;8(1):1–15.
   PubMedGoogle Scholar
• Tripathi AK, Karmakar S, Asthana A, et al. Transport of non-transferrin bound iron to the brain: implications for Alzheimer’s disease. J Alzheimers Dis. 2017;58(4):1109–1119.
   PubMed Web of Science ®Google Scholar
• Jiajia L, Shinghung M, Jiacheng Z, et al. Assessment of neuronal viability using fluorescein diacetate-propidium iodide double staining in cerebellar granule neuron culture. J Vis Exp. 2017; (123):123. DOI:https://doi.org/10.3791/55442.
   Google Scholar